CAS: 1047634-65-0 - Uprosertib
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | GSK2141795 REF: IN-DA008TGRCAS: 1047634-65-0 | 98% | To inquire | Tue 10 Dec 24 |
 | Uprosertib REF: TM-T6849CAS: 1047634-65-0 | 95.62% - 99.54% | 46.00 €~734.00 € | Mon 16 Dec 24 |
 | Uprosertib-13C4d3 REF: TR-U800102CAS: 1047634-65-0 | - - - | 43,894.00 € | Fri 17 Jan 25 |
 | Uprosertib REF: 3D-FU103960CAS: 1047634-65-0 | Min. 95% | To inquire | Tue 21 Jan 25 |
GSK2141795
CAS:1047634-65-0
Formula:
C18H16Cl2F2N4O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
429.2480
Ref: IN-DA008TGR
| 1mg | 55.00 € | ||
| 5mg | 129.00 € | ||
| 10mg | 155.00 € | ||
| 50mg | 553.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Uprosertib
CAS:1047634-65-0
Uprosertib (GSK2141795) is a potent, selective Akt broad-spectrum inhibitor for Akt1/Akt2/Akt3.Cost-effective and quality-assured.
Formula:
C18H16Cl2F2N4O2
Purity:
95.62% - 99.54%
Color and Shape:
Solid
Molecular weight:
429.25
Ref: TM-T6849
| 1mg | 46.00 € | ||
| 2mg | 58.00 € | ||
| 5mg | 83.00 € | ||
| 10mg | 122.00 € | ||
| 25mg | 197.00 € | ||
| 50mg | 317.00 € | ||
| 100mg | 526.00 € | ||
| 200mg | 734.00 € | ||
| 1mL*10mM (DMSO) | 107.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Uprosertib-13C4d3
Controlled ProductCAS:1047634-65-0
Formula:
C14C4H13D3Cl2F2N4O2
Color and Shape:
Neat
Molecular weight:
436.237
Ref: TR-U800102
| 25mg | 43,894.00 € |
Estimated delivery in United States, on Friday 17 Jan 2025
Uprosertib
CAS:1047634-65-0
Inhibitor of ALK kinases; broad spectrum
Formula:
C18H16Cl2F2N4O2
Purity:
Min. 95%
Molecular weight:
429.25 g/mol
Ref: 3D-FU103960
| 1g | To inquire | ||
| 10mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 21 Jan 2025
